A pill for him promises a new era for contraception

Researchers have completed the first human trial of YCT-529, a once-daily, non-hormonal male birth control pill that blocks sperm production by targeting the retinoic acid receptor-alpha. The Phase 1a study in 16 men found no major safety issues, setting the stage for longer trials to measure its effect on sperm counts.

Read the full article at https://www.paperleap.com/blog/articles/a-pill-for-him-promises-a-new-era-for-contraception-0cccc9